Reining in Recurrent Clostridium difficile Infection—Who's at Risk?
- 30 April 2009
- journal article
- editorial
- Published by Elsevier in Gastroenterology
- Vol. 136 (4), 1152-1154
- https://doi.org/10.1053/j.gastro.2009.02.023
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infectionJournal of Hospital Infection, 2008
- Outcomes of Clostridium difficile-Associated Disease Treated With Metronidazole or Vancomycin Before and After the Emergence of NAP1/027American Journal of Gastroenterology, 2007
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Incidence of Clostridium difficile Infection in Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2007
- Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in QuebecCMAJ : Canadian Medical Association Journal, 2005
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone UseInfection Control & Hospital Epidemiology, 2005
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004
- Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaThe Lancet, 2001
- Relapse of Pseudomembranous Colitis after Vancomycin TherapyNew England Journal of Medicine, 1979